All In MedTech

Device Trial Radar · NCT05807321

Fecobionics in Biofeedback Therapy in Dyssynergia Patients

Fecobionics to Monitor and Predict Biofeedback Therapy in Dyssynergia Patients

Last checked: Nov 20, 2026Latest source record: Oct 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Oct 3, 2023

Primary completion

Jan 1, 2027

Study completion Mar 31, 2027

Sponsor

Lead sponsor
The California Medical Innovations Institute, Inc.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Scripps Clinic; Augusta University Medical Center
First posted
Apr 11, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated device
No
Who can join
All sexes, from 21 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Constipation affects 12-19% of Americans. Pelvic floor dyssynergia is considered to play an important role in constipation but the underlying mechanisms are not well understood in individual patients. The investigators have developed a novel device named Fecobionics that provide detailed mapping of physiological parameters during defecation. The aim of the study is to use Fecobionics to assess anorectal function in dyssynergia patients and monitor and predict the outcome of the biofeedback therapy.

Conditions

  • Dyssynergia
  • Constipation

Interventions

  • FecobionicsDevice

    Fecobionics is a novel device to be inserted through the anal canal into rectum for studying defecation. Anorectal manometry and balloon expulsion test may be used as reference. Anorectal manometry and balloon expulsive test are standard methods for anorectal functional measurement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Expulsion DurationTime frame: 1.5 year
  2. Pressure Difference between front and rear ends of FecobionicsTime frame: 1.5 year

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • California Medical Innovations Institute

    San Diego, California · Recruiting

  • Digestive Health Center- Augusta University

    Augusta, Georgia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.